| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2018) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | R03BB08 |
| UNII: | G2AE2VE07O |
Structure
| InChI Key | FYDWDCIFZSGNBU-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C35H43N5O4 |
| Molecular Weight | 597.76 |
| AlogP | 4.84 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 10.0 |
| Polar Surface Area | 108.21 |
| Molecular species | BASE |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 44.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Muscarinic acetylcholine receptor M3 antagonist |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | ||
|
Enzyme
Transferase
|
- | - | - | - | 7.44 | |
|
Enzyme
|
- | - | - | - | ||
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Acetylcholine receptor
|
- | 46.88 | - | - | - |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Liver Diseases | 1 | D008107 | ClinicalTrials |
| Kidney Diseases | 1 | D007674 | ClinicalTrials |
Related Entries
Scaffolds
Adverse Reactions
System Organ Classification (SOC)
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 864750-70-9 |
| ChEMBL | CHEMBL3833319 |
| DrugBank | DB11855 |
| DrugCentral | 5303 |
| FDA SRS | G2AE2VE07O |
| Guide to Pharmacology | 10129 |
| PubChem | 11753673 |
| SureChEMBL | SCHEMBL356480 |
CONTENTS